Connection

Stefano Rusconi to HIV Protease Inhibitors

This is a "connection" page, showing publications Stefano Rusconi has written about HIV Protease Inhibitors.
Connection Strength

0.278
  1. Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects. HIV Clin Trials. 2018 12; 19(6):242-248.
    View in: PubMed
    Score: 0.143
  2. Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial. New Microbiol. 2018 Apr; 41(2):106-111.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.